InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Friday, 12/20/2019 10:33:43 AM

Friday, December 20, 2019 10:33:43 AM

Post# of 811
From the presentation posted 12/19 - 12/20

https://clinicaltrials.gov/ct2/show/NCT03841331
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
Estimated Study Completion Date : January 2020
Ph II TLR anticipated late-Feb 2020
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News